QIAGEN NV (QGEN)

34.04
NYSE : Health Technology
Prev Close 34.08
Day Low/High 33.50 / 34.09
52 Wk Low/High 32.33 / 41.55
Avg Volume 826.00K
Exchange NYSE
Shares Outstanding 226.97M
Market Cap 7.74B
EPS 0.80
P/E Ratio 40.82
Div & Yield N.A. (N.A)
Upgrades Roundup :22 Stocks Rated Buy

Upgrades Roundup :22 Stocks Rated Buy

These stocks received upgrades last week from TheStreet Ratings.

3 Stocks With Upgrades: AOL, Seacor, Qiagen

3 Stocks With Upgrades: AOL, Seacor, Qiagen

These stocks receive upgrades from TheStreet Ratings.

Qiagen NV Stock Upgraded (QGEN)

Qiagen NV Stock Upgraded (QGEN)

Qiagen (Nasdaq:QGEN) has been upgraded by TheStreet Ratings from a hold to buy.

QIAGEN's CEO Discusses Q4 2011 Results - Earnings Call Transcript

QIAGEN's CEO Discusses Q4 2011 Results - Earnings Call Transcript

QIAGEN's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Qiagen NV (QGEN): Today's Featured Diversified Services Loser

Qiagen NV (QGEN): Today's Featured Diversified Services Loser

Qiagen was a leading decliner within the diversified services industry, falling 37 cents (-2.5%) to $14.53 on average volume.

QIAGEN's CEO Hosts Investor Day - Conference Call Transcript

QIAGEN's CEO Hosts Investor Day - Conference Call Transcript

QIAGEN's CEO Hosts Investor Day - Conference Call Transcript

QIAGEN's CEO Discusses Q3 2011 Results - Earnings Call Transcript

QIAGEN's CEO Discusses Q3 2011 Results - Earnings Call Transcript

QIAGEN's CEO Discusses Q3 2011 Results - Earnings Call Transcript

7 Stocks Rising on Huge Volume

7 Stocks Rising on Huge Volume

Here's a look at the technicals of six stocks rising today on above-average trading volume.

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen (Nasdaq:QGEN) hit a new 52-week low Tuesday as it is currently trading at $12.50, below its previous 52-week low of $12.63 with 1.2 million shares traded as of 10:06 a.m. ET. Average volume has been 2.3 million shares over the past 30 days.

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen (Nasdaq:QGEN) hit a new 52-week low Wednesday as it is currently trading at $12.93, below its previous 52-week low of $12.98 with 183,771 shares traded as of 9:30 a.m. ET. Average volume has been 2.2 million shares over the past 30 days.

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen (Nasdaq:QGEN) hit a new 52-week low Thursday as it is currently trading at $13.48, below its previous 52-week low of $13.51 with 89,355 shares traded as of 9:50 a.m. ET. Average volume has been 2.3 million shares over the past 30 days.

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen (Nasdaq:QGEN) hit a new 52-week low Friday as it is currently trading at $13.95, below its previous 52-week low of $13.99 with 767,538 shares traded as of 11:30 a.m. ET. Average volume has been 2.9 million shares over the past 30 days.

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen (Nasdaq:QGEN) hit a new 52-week low Wednesday as it is currently trading at $14.25, below its previous 52-week low of $14.27 with 253,097 shares traded as of 10:21 a.m. ET. Average volume has been 2.7 million shares over the past 30 days.

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen Stock Hits New 52-Week Low (QGEN)

Qiagen (Nasdaq:QGEN) hit a new 52-week low Tuesday as it is currently trading at $16.31, below its previous 52-week low of $16.35 with 66,799 shares traded as of 9:34 a.m. ET. Average volume has been 2.4 million shares over the past 30 days.

TheStreet Ratings Top 10 Rating Changes

TheStreet Ratings Top 10 Rating Changes

TheStreet Ratings released rating changes on 103 U.S. common stocks for week ending July 29, 2011. 61 stocks were upgraded and 42 stocks were downgraded by our stock model.

Qiagen NV Stock Downgraded (QGEN)

Qiagen NV Stock Downgraded (QGEN)

Qiagen (Nasdaq:QGEN) has been downgraded by TheStreet Ratings from from a buy to hold.

Qiagen's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Qiagen's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Qiagen's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Qiagen Rises On Unusually High Volume (QGEN)

Qiagen Rises On Unusually High Volume (QGEN)

Qiagen (Nasdaq:QGEN) is trading at unusually high volume Monday with 5.7 million shares changing hands. It is currently at four times its average daily volume and trading up 56 cents (+3%).

Incubators Spawn Ideas, Money for IBM, AOL

Incubators Spawn Ideas, Money for IBM, AOL

IBM, AOL, Texas Instruments and other large companies serve as mentors -- and potential acquirers -- at the country's 1,400 business incubators.

FDA Approves 2 New HPV Tests From Hologic

FDA approves 2 genetic tests from Hologic to assess the risks of cervical cancer

TSC Ratings' Updates: Nvidia

TSC Ratings' Updates: Nvidia

Hercules Offshore, Lions Gate, Nvidia and ProLogis are downgraded; Qiagen is upgraded.

Health Winners & Losers: Halozyme

Health Winners & Losers: Halozyme

Halozyme climbs on drug study data.

The Real Winners of Drug Experimentation

The Real Winners of Drug Experimentation

The companies that supply the tools needed for pharma research and development often profit no matter the success of a drug trial.

China Selloff Not So Scary

China Selloff Not So Scary

Amid robust M&A, the unraveling of Shanghai speculation is having a limited global effect -- for now.

TheStreet Quant Rating: B (Buy)